Impact of weight gain with dolutegravir on antiretroviral adherence and viral suppression in four African countries.
Sign Up to like & getrecommendations! Published in 2023 at "HIV medicine"
DOI: 10.1111/hiv.13501
Abstract: OBJECTIVE We hypothesized that total body weight (TBW) gain after switching antiretroviral therapy (ART) regimen to tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) may negatively impact ART adherence and viral load (VL) and therefore sought to examine these… read more here.
Keywords: tbw gain; adherence; gain; impact weight ... See more keywords